請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23293完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 程蘊菁(Yen-Ching Chen) | |
| dc.contributor.author | Tsung-Yen Yang | en |
| dc.contributor.author | 楊宗彥 | zh_TW |
| dc.date.accessioned | 2021-06-08T04:58:51Z | - |
| dc.date.copyright | 2010-09-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-08-19 | |
| dc.identifier.citation | 1. Department of Health EY, R.O.C (Taiwan). 2008 Cause of Death Statistics 2009.
2. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54. 3. Papathanassoglou ED, Giannakopoulou MD, Bozas E. Genomic variations and susceptibility to sepsis. AACN Adv Crit Care 2006;17:394-422. 4. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709. 5. Hack CE, De Groot ER, Felt-Bersma RJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-10. 6. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992;215:356-62. 7. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993;103:565-75. 8. Soderquist B, Sundqvist KG, Vikerfors T. Kinetics of serum levels of interleukin-6 in Staphylococcus aureus septicemia. Scand J Infect Dis 1992;24:607-12. 9. Gebhard F, Pfetsch H, Steinbach G, et al. Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 2000;135:291-5. 10. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28:108-21. 11. Kitanovski L, Jazbec J, Hojker S, et al. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis 2006;25:413-5. 12. Strait RT, Kelly KJ, Kurup VP. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 levels in febrile, young children with and without occult bacteremia. Pediatrics 1999;104:1321-6. 13. Moscovitz H, Shofer F, Mignott H, et al. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994;22:1102-7. 14. Malik A, Hui CP, Pennie RA, et al. Beyond the complete blood cell count and C-reactive protein: a systematic review of modern diagnostic tests for neonatal sepsis. Arch Pediatr Adolesc Med 2003;157:511-6. 15. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481-3. 16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. 17. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8. 18. LeGall JR, Loirat P, Alperovitch A. APACHE II--a severity of disease classification system. Crit Care Med 1986;14:754-5. 19. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999;11:7-12. 20. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800. 21. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10. 22. Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-8. 23. Lee NY, Lee HC, Ko NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28:713-9. 24. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007;167:1655-63. 25. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003;37:230-7. 26. Grmec S, Gasparovic V. Comparison of APACHE II, MEES and Glasgow Coma Scale in patients with nontraumatic coma for prediction of mortality. Acute Physiology and Chronic Health Evaluation. Mainz Emergency Evaluation System. Crit Care 2001;5:19-23. 27. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218:769-76. 28. Thorand B, Baumert J, Doring A, et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184:216-24. 29. Tchernof A, Despres JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res 2000;32:526-36. 30. Thorand B, Baumert J, Kolb H, et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 2007;30:854-60. 31. Liu S, Tinker L, Song Y, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007;167:1676-85. 32. Figaro MK, Kritchevsky SB, Resnick HE, et al. Diabetes, inflammation, and functional decline in older adults: findings from the Health, Aging and Body Composition (ABC) study. Diabetes Care 2006;29:2039-45. 33. Dalla Vestra M, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol 2005;16 Suppl 1:S78-82. 34. Natali A, Toschi E, Baldeweg S, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 2006;55:1133-40. 35. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421. 36. Krabbe KS, Bruunsgaard H, Hansen CM, et al. Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 2001;8:333-8. 37. Watanabe E, Hirasawa H, Oda S, et al. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 2005;33:89-97; discussion 242-3. 38. Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care 2004;8:R82-90. 39. Kragsbjerg P, Holmberg H, Vikerfors T. Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand J Infect Dis 1996;28:391-8. 40. Dofferhoff AS, de Jong HJ, Bom VJ, et al. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 1992;24:197-204. 41. Dofferhoff AS, Bom VJ, de Vries-Hospers HG, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992;20:185-92. 42. Shin SH, Shin DH, Ryu PY, et al. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera. FEMS Immunol Med Microbiol 2002;33:133-8 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23293 | - |
| dc.description.abstract | 背景. 敗血症的嚴重程度與血中細胞激素的上升與持續時間長短是被認為有相關性的存在。而在所有與敗血症相關的細胞激素中，細胞激素介白質6在對抗侵入的微生物所產生的發炎反應中佔有著重要的角色。但是先前的研究並沒有清楚的探討菌血症病人血漿中介白質激素6的濃度高低與之後敗血症的嚴重程度之相關性。
研究方法. 本研究總共收集了109位來自於台灣北部一家區域教學醫院的普通病房及加護病房之菌血症住院病人。每一位菌血症住院病人於告知病情取得同意書後，各抽取兩次血液檢體，且兩次檢體時間至少間隔48個小時以上。 研究結果.在患有糖尿病的菌血症病人中且血漿中介白質激素6為最低的三分之一層級者比起最高的三分之一層級者，敗血症的嚴重程度相對來說是有較低的危險相關性 (OR=0.13, 95% CI=0.02- 0.82)。在年齡大於等於75歲的菌血症病人，血漿中介白質激素6持續上升與器官功能衰竭是有顯著危險相關性的存在 (OR=9.36, 95% CI=1.59- 55.10)。在革蘭氏陽性球菌菌血症病人比起革蘭氏陰性桿菌菌血症病人與血漿介白質激素6的升高有較大的關聯性 (OR=2.58 95% CI=1.03-6.46)。在革蘭氏陽性球菌菌血病人帶有褥瘡者比起革蘭氏陰性桿菌菌血症帶有褥瘡者也是與血漿中介白質激素6的上升有關聯 (OR=12.15, 95% CI=1.17- 125.61)。在革蘭氏陽性球菌菌血病人未在48小時內接受適當抗生素治療者比起同樣未接受適當抗生素治療的革蘭氏陰性桿菌菌血症的患者也是與血漿中介白質激素6的上升有關聯性 (OR=9.44, 95% CI=1.34- 66.28)。 結論. 血漿中介白質激素6是關於敗血症的嚴重程度的預測因子並且與引起菌血症的菌種不同而有關聯性存在。 | zh_TW |
| dc.description.abstract | Background. The severity of sepsis has been associated with high and sustained cytokine levels. Interleukin 6 (IL-6) plays a pivotal role in the inflammatory response against pathogens. However, the association between plasma IL-6 levels in bacteremic patients and the severity of sepsis has not been well explored.
Methods. A total of 108 bacteremic patients were recruited from the general ward and intensive care unit (ICU) of a teaching hospital in northern Taiwan. For each patient, two plasma IL-6 levels were determined at least 48 hours apart after admission to the general ward and ICU. Results. Among bacteremic patients with diabetes mellitus (DM), the lowest tertile of the first plasma IL-6 level was associated with a reduced risk of severe sepsis (OR=0.13, 95% CI=0.02-0.82) compared with the highest tertile. Sustained elevation of IL-6 was associated with organ dysfunction in patients 75 old and older (OR=9.36, 95% CI=1.59-55.10). Bacteremic patients with G (+) cocci infection had higher plasma IL-6 levels (OR=2.58, 95% CI=1.03-6.46) than those with G (-) bacilli. Among bacteremic patients with pressure ulcers, those with G (+) cocci infection had higher plasma IL-6 levels (OR=12.15, 95% CI=1.17-125.61) than those with G (-) bacilli infection. Discordant antibiotic therapy in patients with G (+) cocci bacteremia was related to an increased plasma IL-6 level (OR=9.44, 95% CI=1.34-66.28) compared with that in those with G (-) bacilli. Conclusion. Plasma IL-6 is an important predictor of sepsis severity and this association varies by the type of causative pathogen. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T04:58:51Z (GMT). No. of bitstreams: 1 ntu-99-R97846014-1.pdf: 447468 bytes, checksum: 992842441ab41025b207d39a37ac8e27 (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 口試委員會審定書 2
Acknowledgements 6 中文摘要 7 Abstract 8 Chapter 1. Introduction 9 1.1 Importance of bacteremic sepsis 9 1.2 Interleukin-6 and sepsis 9 1.3 Previous studies 10 1.4 Aims 10 Chapter 2. Materials and Methods 11 2.1 Study population 11 2.2 Data collection and biospecimens 11 2.3 Outcome Ascertainment 12 2.4 Statistical analysis 14 Chapter 3 Results 16 3.1 Patient characteristics 16 3.2 First plasma IL-6 levels and severity of sepsis 17 3.3 First plasma IL-6 levels and types of pathogens 18 Chapter 4. Discussion 20 4.1 Main findings 20 4.2 Comparison with previous studies 20 4.3 Strengths and limitations 22 Chapter 5. Conclusion 24 References 25 Figures and tables 30 Appendix 45 | |
| dc.language.iso | en | |
| dc.subject | 糖尿病 | zh_TW |
| dc.subject | 菌血症 | zh_TW |
| dc.subject | 敗血症 | zh_TW |
| dc.subject | 介白質激素6 | zh_TW |
| dc.subject | 器官衰竭 | zh_TW |
| dc.subject | Bacteremia | en |
| dc.subject | diabetes mellitus | en |
| dc.subject | organ dysfunction | en |
| dc.subject | interleukin 6 | en |
| dc.subject | sepsis | en |
| dc.title | 血漿中介白質激素6之濃度與成人菌血症風險之關聯研究 | zh_TW |
| dc.title | Association between Plasma Interleukin 6 Levels and Risk of Adult Bacteremia | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 黃立民(Li-Min Huang) | |
| dc.contributor.oralexamcommittee | 張鑾英(Luan-Yin Chang) | |
| dc.subject.keyword | 菌血症,敗血症,介白質激素6,器官衰竭,糖尿病, | zh_TW |
| dc.subject.keyword | Bacteremia,sepsis,interleukin 6,organ dysfunction,diabetes mellitus, | en |
| dc.relation.page | 49 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2010-08-19 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 預防醫學研究所 | zh_TW |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 436.98 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。